Physician profile
John Lin
NPI 1972593929
$418.22
in general payments reported to CMS, 2019-2025
10 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $101 · 2022: $29.12 · 2023: $24.84 · 2024: $79.53 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $288.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $111.41 | 2025 | Spaceoar Vue System - 10ml |
| Abbvie INC. | $82.46 | 2024-2025 | |
| Amag Pharmaceuticals, INC. | $60.60 | 2021 | |
| Stemline Therapeutics INC. | $29.76 | 2025 | Orserdu |
| C. R. Bard, INC. & Subsidiaries | $29.12 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.90 | 2021 | |
| Eisai INC. | $24.84 | 2023 | |
| Daiichi Sankyo INC. | $24.33 | 2025 | Injectafer |
| Janssen Biotech, INC. | $15.72 | 2024 | Erleada |
| Rochester Medical Corporation | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.